Effects of interferon-τ on cattle persistently infected with bovine viral diarrhea virus

Japanese Journal of Veterinary Research

Volumn 60, Issue 2-3, 2012, Pages 63-70

  Kohara, Junko ^a   Nishikura, Yumiko ^b   Konnai, Satoru ^b   Tajima, Motoshi ^b   Onuma, Misao ^b  

^a HOKKAIDO RESEARCH ORGANIZATION   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Bovine viral diarrhea virus; Cattle; Interferon t; Persistent infection

Indexed keywords

ANTIVIRUS AGENT; INTERFERON; PLACENTA PROTEIN; RECOMBINANT PROTEIN; TROPHOBLAST PROTEIN 1;

ANIMAL; ARTICLE; BOVINE DIARRHEA VIRUS; BOVINE VIRAL DIARRHEA; CATTLE; DRUG EFFECT; FEMALE; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; VIROLOGY; VIRUS LOAD;

ANIMALS; ANTIVIRAL AGENTS; BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE; CATTLE; DIARRHEA VIRUSES, BOVINE VIRAL; FEMALE; INTERFERON TYPE I; PREGNANCY PROTEINS; RECOMBINANT PROTEINS; VIRAL LOAD;

BOS; BOVINAE; BOVINE VIRAL DIARRHEA VIRUS 1;

EID: 84867158176     PISSN: 00471917     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Baker, J. C. 1995. The clinical manifestations of bovine viral diarrhea infection. Vet. Clin. North Am. Food Anim. Pract., 11: 425-445.
2. Charleston, B., Fray, M. D., Baigent, S., Carr, B. V. and Morrison, W. I. 2001. Establishment of persistent infection with non-cytopathic bovine viral diarrhea virus in cattle is associated with a failure to induce type 1 interferon. J. Gen. Virol., 82: 1893-1897.
3. Houe, H. 1999. Epidemiological features and economical importance of bovine virus diarrhoea virus (BVDV) infections. Vet. Microbiol., 64: 89-107.
4. Imakawa, K., Anthony R. V., Kazemi, M., Marotti, K. R., Polites, H. G. and Roberts, R. M. 1987. Interferon-like sequence of ovine trophoblast protein secreted by embryonic trophectoderm. Nature, 330: 377-379.
5. Johnson, J. A., Hochkeppel, H. K. and Gangemi, J. D. 1999. IFN-tau exhibits potent suppression of human papillomavirus E6/E7 oncoprotein expression. J. Interferon Cytokine Res., 19: 1107-1116.
6. Johnson, G. A., Stewart, M. D., Gray, C. A., Choi, Y., Burghardt, R. C., Yu-Lee, L., Bazer, F. W. and Spencer, T. E. 2001. Effects of the estrous cycle, pregnancy, and interferon tau on 2', 5'-oligoadenylate synthetase expression in the ovine uterus. Biol. Reprod., 64: 1392-1399.
7. Kodama, K., Sasaki, N., Fukuyama, S., Izumida, A. and Ishii, F. 1974. Studies on cytopathogenic bovine viral diarrhea virus recovery, identification, and properties of the isolated virus. Bull. Nippon Vet. Zootech. Coll., 23: 51-60.
8. Kohara, J. and Yokomizo, Y. 2007. In vitro and in vivo effects of recombinant bovine interferon-τ on bovine leukemia virus. J. Vet. Med. Sci., 69: 15-19.
9. Nagai, M., Sato, M., Nagano, H., Pang, H., Kong, X., Murakami, T., Ozawa, T. and Akashi, H. 1998. Nucleotide sequence homology to bovine viral diarrhea virus 2 (BVDV 2) in the 5' untranslated region of BVDVs from cattle with mucosal disease or persistent infection in Japan. Vet. Microbiol., 60: 271-276.
10. Nagaya, H., Kanaya, T., Kaki, H., Tobita, Y., Takahashi, M., Takahashi, H., Yokomizo, Y. and Inumaru, S. 2004. Establishment of a large-scale purification procedure for purified recombinant bovine interferon-τ produced by a silkworm-baculovirus gene expression system. J. Vet. Med. Sci., 66: 1395-1401.
11. Omori, T., Inaba, Y., Morimoto, T., Tanaka, Y., Kurogi, H. and Matsumoto, M. 1967. Bovine diarrhea virus. I. Isolation of non-cytopathogenic Microbiol., 11: 133-142.
12. Peek, S. F., Bonds, M. D., Gangemi, D. G., Thomas, C. B. and Schultz, R. D. 2004a. Evaluation of cytotoxicity and antiviral activity of recombinant human interferon alfa-2a and recombinant human interferon alfa-B/D hybrid against bovine viral diarrhea virus, infectious bovine rhinotracheitis virus, and vesicular stomatitis virus in vitro. Am. J. Vet. Res., 65: 871-874.
13. Peek, S. F., Bonds, M. D., Schaele, P., Weber, S., Friedrichs, K. and Schultz, R. D. 2004b. Evaluation of antiviral activity and toxicity of recombinant human interferon alfa-2a in calves persistently infected with type 1 bovine viral diarrhea virus. Am. J. Vet. Res., 65: 865-870.
14. Pontzer, C. H., Yamamoto, J. K., Bazer, F. W., Ott, T. L. and Johnson, H. M. 1997. Potent anti-feline immunodeficiency virus and antihuman immunodeficiency virus effect of IFN-τ. J. Immunol., 158: 4351-4357.
15. Roberts, R. M., Cross, J. C. and Leaman, D. W. 1992. Interferons as hormons of pregnancy. Endocr. Rev., 13: 432-452.
16. Rogez, C., Martin, M., Dereuddre-Bosquet, N., Martal, J., Dormont, D. and Clayette, P. 2003. Anti-human immunodeficiency virus activity of τ interferon in human macrophages: Involvement of cellular factors and β-chemokines. J. Virol., 77: 12914-12920.
17. Saliki, J. T., Fulton, R. W., Hull, S. R. and Dubovi, E. J. 1997. Microtiter virus isolation and enzyme immunoassays for detection of bovine viral diarrhea virus in cattle serum. J. Clin. Microbiol., 35: 803-807.
18. Schweizer, M. and Peterhans, E. 2001. Non-cytopathic bovine viral diarrhea virus inhibits double-stranded RNA-induced apoptosis and interferon synthesis. J. Virol., 75: 4692-4698.
19. Schweizer, M., Mätzener, P., Pfaffen, G., Stalder, H. and Peterhans, E. 2006. "Self" and "nonself" manipulation of interferon defense during persistent infection: Bovine viral diarrhea virus resists alpha/beta interferon without blocking antiviral activity against unrelated viruses replicating in its host cells. J. Virol., 80: 6926-6935.
20. Sentsui, H., Takami, R., Nishimori, T., Murakami, K., Yokoyama, T. and Yokomizo, Y. 1998. Anti-viral effect of interferon-alpha on bovine viral diarrhea virus. J. Vet. Med. Sci., 60: 1329-1333.
21. Short, Jr. E. C. and Fulton, R. W. 1987. Induction and measurement of 2', 5'-oligoadenylate synthetase in Madin-Darby bovine kidney cells and in cattle. J. Clin. Microbiol., 25: 1735-1740.
22. Subramaniam, P. S., Khan, S. A., Pontzer, C.H. and Johnson, H.M. 1995. Differential recognition of the type I interferon receptor by interferons τ and α is responsible for their disparate cytotoxicities. Proc. Natl. Acad. Sci. U. S. A., 92: 12270-12274.